Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Premium Healthcare GroupCAI:PHGC -1.15% 3-Year RORE % is 0.00 as of . 20. Among 200 Medical Diagnostics & Research companies, Premium Healthcare Group ranks worse than 499999.5% on this metric.
Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments.
Premium Healthcare Group does not have enough data to calculate 3-Year RORE %.
Premium Healthcare Group (CAI:PHGC) 3-Year RORE % Explanation
Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.
There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.
Be Aware
Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.
Premium Healthcare Group 3-Year RORE % Related Terms
Premium Healthcare Group 3-Year RORE % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Premium Healthcare Group 3-Year RORE % Chart
Premium Healthcare Group Annual Data
Trend
3-Year RORE %
Premium Healthcare Group Semi-Annual Data
3-Year RORE %
CAI:PHGC vs TMO, DHR, IDXX: 3-Year RORE % Comparison
For the Diagnostics & Research subindustry, Premium Healthcare Group's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Premium Healthcare Group 3-Year RORE % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Premium Healthcare Group's 3-Year RORE % distribution charts can be found below:
* The bar in red indicates where Premium Healthcare Group's 3-Year RORE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in . 20 and 3-year before.
Premium Healthcare Group (CAI:PHGC) has a 3-Year RORE % of 0.00 as of . 20. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Premium Healthcare Group and its competitors. According to the industry distribution chart, Premium Healthcare Group ranks #999999 out of 200 companies in the Medical Diagnostics & Research industry.
Is Premium Healthcare Group's 3-Year RORE % too high?
Premium Healthcare Group's current 3-Year RORE % is 0.00. Based on the distribution chart, Premium Healthcare Group ranks #999999 out of 200 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers.
How does Premium Healthcare Group's 3-Year RORE % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Premium Healthcare Group ranks #999999 out of 200 companies for 3-Year RORE %. This places Premium Healthcare Group in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year RORE % for a Medical Diagnostics & Research company?
A good 3-Year RORE % depends on the Medical Diagnostics & Research industry context. However, 3-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year RORE % mean?
A high 3-Year RORE % can signal that a stock is expensive relative to its fundamentals. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Premium Healthcare Group and its competitors. Premium Healthcare Group's current 3-Year RORE % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Premium Healthcare Group stock overvalued right now?
Premium Healthcare Group (CAI:PHGC) has a current 3-Year RORE % of 0.00. The current 3-Year RORE % is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year RORE % calculated?
3-Year RORE % is calculated from a company's financial statements. For Premium Healthcare Group (CAI:PHGC), the current 3-Year RORE % is 0.00 as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Premium Healthcare Group Formerly City Lab is a company whose main purpose is to establish, operate and manage medical analysis laboratories, and import supplies and equipments, medical analysis laboratories.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CAI:PHGC has been successfully added to your 
